A non-randomized, open-label, single-dose, crossover study to evaluate the dose proportionality of the final fixed dose combination formulation of Coreg CR [carvedilol] and lisinopril.
Phase of Trial: Phase I
Latest Information Update: 14 Oct 2010
At a glance
- Drugs Carvedilol/lisinopril (Primary)
- Indications Hypertension
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 14 Oct 2010 Last checked against ClinicalTrials.gov record.
- 21 Apr 2008 Status changed from recruiting to completed according to ClinicalTrials.gov.
- 12 Nov 2007 New trial record.